Posted by Michael Wonder on 30 Jan 2018
Prescription medicines and biologicals: TGA annual summary 2017
30 January 2018 - This is TGA's fourth annual summary report on the registration of prescription medicines, which includes new generic and biosimilar medicines.
The summary also showcases new biologicals, including human cell- and tissue-derived products; and Australian Public Assessment Reports (AusPARs) published on our website during 2017.
For the first time, the summary contains Priority review determinations. Priority review involves a faster assessment of certain prescription medicines, with a 3-month shorter timeframe than the standard registration process.
